Clinical and pharmacokinetics equivalence of multiple doses of levodopa benserazide generic formulation vs the originator (Madopar)

AIMS: While several generic preparations of levodopa/carbidopa and levodopa/benserazide (LBD) are currently available, pharmacokinetic (PK) equivalence and therapeutic equivalence studies with levodopa generics are not available in Italy. Lack of data on generic formulations is a critical factor for...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Br J Clin Pharmacol
Main Authors: Torti, Margherita, Alessandroni, Jhessica, Bravi, Daniele, Casali, Miriam, Grassini, Paola, Fossati, Chiara, Ialongo, Cristiano, Onofrj, Marco, Radicati, Fabiana Giada, Vacca, Laura, Bonassi, Stefano, Stocchi, Fabrizio
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6848900/
https://ncbi.nlm.nih.gov/pubmed/31378952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14086
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares